Hospital Ramón y Cajal | Oncología

Madrid 28034

0 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, Neoplasms, Urothelial Carcinoma

Studies at this site

• Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma — Completed
• A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer — Completed
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed